Biolux Technology, a leader in orthodontic technology, has successfully raised $4.5 million in seed funding to launch a new digital platform for its flagship product, OrthoPulse. The investment, led by redalpine and Revere Partners, will also be used to advance clinical research and scale operations. Furthermore, Biolux has appointed Raphael Pascaud as Chairman of the Board to guide the company through its next phase of growth.
The new digital platform for OrthoPulse will offer real-time monitoring and treatment optimization for orthodontists and patients. This will revolutionize the orthodontic experience by providing faster and more efficient treatment options.
Raphael Pascaud, with his extensive experience in the dental industry, will play a key role in leading Biolux through its growth and innovation. The partnership with redalpine and Revere Partners, coupled with Pascaud’s leadership, positions Biolux for rapid expansion in the orthodontic market.
The patented light-accelerated technology of OrthoPulse aims to provide more reliable treatment and accelerate tooth movement using safe near-infrared light therapy. The funding will drive the development of new innovative solutions and advance clinical research to further enhance patient outcomes and user experience.
With Biolux’s commitment to revolutionize orthodontics and deliver exceptional care, the company is poised to make significant advancements in the orthodontic industry.
Source
Photo credit orthodonticproductsonline.com
